{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:49:32Z","timestamp":1773409772016,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Testicular germ cell tumors (TGCT) pose a threat to men\u2019s health, discovery of small molecule compounds with potent antiproliferative activity against testicular germ cells is of great significance. Lysine-specific demethylase 1 (LSD1) is overexpressed in tumoral testicular germ cell lines, and it is a promising target for developing agents against TGCT. A series of natural apigenin analogues were evaluated for their inhibitory activity against LSD1, and their structure activity relationships (SARs) were explored. Among them, 8,3\u2019-diprenylapigenin exhibited the most potent inhibitory activity against LSD1 with an IC\n                    <jats:sub>50<\/jats:sub>\n                    value of 3.60 \u00b5M. 7-hydroxy of 8,3\u2019-diprenylapigenin formed a hydrogen bond with Ala809 of LSD1, demonstrating that 7-hydroxy was a dominant group. In addition, 8,3\u2019-diprenylapigenin reversibly and selectively inhibited LSD1 in a concentration-dependent and time-dependent manner. It inhibited proliferation against tumoral testicular germ cell lines NCCIT and NTERA-2 with IC\n                    <jats:sub>50<\/jats:sub>\n                    values of 9.37 \u00b5M and 5.26 \u00b5M, respectively. Mechanism studies revealed that 8,3\u2019-diprenylapigenin induced the generation of ROS, inhibited the activity of catalase and decreased the level of ATP in NTERA-2 cells. Meanwhile, it also activated the release of LDH, increased the activity of SOD and enhanced the level of MDA in NTERA-2 cells. These findings indicated that 8,3\u2019-diprenylapigenin is a novel reversible LSD1 inhibitor and deserves further exploration to treat testicular germ cell tumors.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-42263-y","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T22:16:03Z","timestamp":1772489763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of natural apigenin analogues as lysine-specific demethylase 1 inhibitors against tumoral testicular germ cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Li-Wei","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai-Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"42263_CR1","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/jama.2024.27122","volume":"333","author":"N Singla","year":"2025","unstructured":"Singla, N., Bagrodia, A., Baraban, E., Fankhauser, C. D. & Ged, Y. M. A. Testicular Germ Cell. Tumors: Rev. JAMA 333, 793\u2013803. https:\/\/doi.org\/10.1001\/jama.2024.27122 (2025).","journal-title":"Testicular Germ Cell. Tumors: Rev. JAMA"},{"key":"42263_CR2","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ng.394","volume":"41","author":"EA Rapley","year":"2009","unstructured":"Rapley, E. A. et al. A genome-wide association study of testicular germ cell tumor. Nat. Genet. 41, 807\u2013810. https:\/\/doi.org\/10.1038\/ng.394 (2009).","journal-title":"Nat. Genet."},{"key":"42263_CR3","doi-asserted-by":"publisher","first-page":"9247","DOI":"10.1038\/s41467-024-53193-6","volume":"15","author":"M N\u00ed Leathlobhair","year":"2024","unstructured":"N\u00ed Leathlobhair, M. et al. Genomic landscape of adult testicular germ cell tumours in the 100,000 Genomes Project. Nat. Commun. 15, 9247. https:\/\/doi.org\/10.1038\/s41467-024-53193-6 (2024).","journal-title":"Nat. Commun."},{"key":"42263_CR4","doi-asserted-by":"publisher","first-page":"e80919","DOI":"10.7759\/cureus.80919","volume":"17","author":"O Durrani","year":"2025","unstructured":"Durrani, O., Arif, U., Baig, H., Khalil, T. & Nandwani, G. Preserving Reproductive Potential in the Solitary Testis With Germ Cell Tumour and Azoospermia Using Onco-Testicular Sperm Extraction (TESE): A Case Report. Cureus 17, e80919. https:\/\/doi.org\/10.7759\/cureus.80919 (2025).","journal-title":"Cureus"},{"key":"42263_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/andr.13485","volume":"12","author":"AS Neyroud","year":"2024","unstructured":"Neyroud, A. S. et al. Sperm DNA methylation dynamics after chemotherapy: a longitudinal study of a patient with testicular germ cell tumor treatment. Andrology 12, 396\u2013409. https:\/\/doi.org\/10.1111\/andr.13485 (2024).","journal-title":"Andrology"},{"key":"42263_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.euf.2022.11.001","volume":"9","author":"A Heidenreich","year":"2023","unstructured":"Heidenreich, A., Seelemeyer, F., Altay, B. & Laguna, M. P. Testis-sparing Surgery in Adult Patients with Germ Cell Tumors: Systematic Search of the Literature and Focused Review. Eur. Urol. Focus. 9, 244\u2013247. https:\/\/doi.org\/10.1016\/j.euf.2022.11.001 (2023).","journal-title":"Eur. Urol. Focus"},{"key":"42263_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1442-2042.2006.01645.x","volume":"14","author":"H Sakamoto","year":"2007","unstructured":"Sakamoto, H. et al. Testicular sperm extraction in patients with persistent azoospermia after chemotherapy for testicular germ cell tumor. Int. J. Urol. 14, 167\u2013170. https:\/\/doi.org\/10.1111\/j.1442-2042.2006.01645.x (2007).","journal-title":"Int. J. Urol."},{"key":"42263_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0302-2838(02)00274-9","volume":"42","author":"KD Jacobsen","year":"2002","unstructured":"Jacobsen, K. D. et al. Gonadal Function and Fertility in Patients with Bilateral Testicular Germ Cell Malignancy. Eur. Urol. 42, 229\u2013238. https:\/\/doi.org\/10.1016\/S0302-2838(02)00274-9 (2002).","journal-title":"Eur. Urol."},{"key":"42263_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0140-6736(25)00455-6","volume":"406","author":"J Chavarriaga","year":"2025","unstructured":"Chavarriaga, J., Nappi, L., Papachristofilou, A., Conduit, C. & Hamilton, R. J. Testicular cancer. Lancet 406, 76\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(25)00455-6 (2025).","journal-title":"Lancet"},{"key":"42263_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s13402-017-0326-8","volume":"40","author":"C Rudolph","year":"2017","unstructured":"Rudolph, C. et al. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours. Cell. Oncol 40, 341\u2013355. https:\/\/doi.org\/10.1007\/s13402-017-0326-8 (2017).","journal-title":"Cell. Oncol"},{"key":"42263_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2174\/1574892814666190111120023","volume":"14","author":"C Paolo","year":"2019","unstructured":"Paolo, C., Marco De, M. & Francesco, E. New anti-cancer strategies in testicular germ cell tumors. Recent. Pat. Anticancer. Drug. Discov 14, 53\u201359. https:\/\/doi.org\/10.2174\/1574892814666190111120023 (2019).","journal-title":"Recent. Pat. Anticancer. Drug. Discov"},{"key":"42263_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-021-00737-3","volume":"28","author":"D Kim","year":"2021","unstructured":"Kim, D., Kim, K. I. & Baek, S. H. Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases. J. Biomed. Sci. 28, 41. https:\/\/doi.org\/10.1186\/s12929-021-00737-3 (2021).","journal-title":"J. Biomed. Sci."},{"key":"42263_CR13","doi-asserted-by":"publisher","first-page":"5479","DOI":"10.1158\/0008-5472.CAN-17-0496","volume":"77","author":"Y Liang","year":"2017","unstructured":"Liang, Y. et al. LSD1-mediated epigenetic reprogramming drives CENPE expression and prostate cancer progression. Cancer Res. 77, 5479\u20135490. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0496 (2017).","journal-title":"Cancer Res."},{"key":"42263_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01557-1","volume":"21","author":"D-D Shen","year":"2022","unstructured":"Shen, D.-D. et al. LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer. Mol. Cancer 21, 75. https:\/\/doi.org\/10.1186\/s12943-022-01557-1 (2022).","journal-title":"Mol. Cancer"},{"key":"42263_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23123194","volume":"23","author":"G-J Yang","year":"2018","unstructured":"Yang, G.-J., Lei, P.-M., Wong, S.-Y., Ma, D.-L. & Leung, C.-H. Pharmacological inhibition of LSD1 for cancer treatment. Molecules 23, 3194. https:\/\/doi.org\/10.3390\/molecules23123194 (2018).","journal-title":"Molecules"},{"key":"42263_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1120911","volume":"14","author":"B Noce","year":"2023","unstructured":"Noce, B., Di Bello, E., Fioravanti, R. & Mai, A. LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials. Front. Pharmacol. 14, 1120911. https:\/\/doi.org\/10.3389\/fphar.2023.1120911 (2023).","journal-title":"Front. Pharmacol."},{"key":"42263_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/14728214.2019.1694001","volume":"24","author":"MR Pandey","year":"2019","unstructured":"Pandey, M. R. & Wang, E. S. What potential is there for LSD1 inhibitors to reach approval for AML? Expert Opin. Emerg. Drugs. 24, 205\u2013212. https:\/\/doi.org\/10.1080\/14728214.2019.1694001 (2019).","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"42263_CR18","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1002\/tcr.201810031","volume":"18","author":"Y Ota","year":"2018","unstructured":"Ota, Y. & Suzuki, T. Drug Design Concepts for LSD1-Selective Inhibitors. Chem. Rec. 18, 1782\u20131791. https:\/\/doi.org\/10.1002\/tcr.201810031 (2018).","journal-title":"Chem. Rec"},{"key":"42263_CR19","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1021\/acschembio.3c00386","volume":"18","author":"S Baby","year":"2023","unstructured":"Baby, S., Shinde, S. D., Kulkarni, N. & Sahu, B. Lysine-Specific Demethylase 1 (LSD1) Inhibitors: Peptides as an Emerging Class of Therapeutics. ACS Chem. Biol. 18, 2144\u20132155. https:\/\/doi.org\/10.1021\/acschembio.3c00386 (2023).","journal-title":"ACS Chem. Biol."},{"key":"42263_CR20","doi-asserted-by":"publisher","first-page":"114818","DOI":"10.1016\/j.ejmech.2022.114818","volume":"244","author":"CM Mills","year":"2022","unstructured":"Mills, C. M. et al. Synthesis and evaluation of small molecule inhibitors of LSD1 for use against MYCN-expressing neuroblastoma. Eur. J. Med. Chem. 244, 114818. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114818 (2022).","journal-title":"Eur. J. Med. Chem."},{"key":"42263_CR21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.bmc.2017.12.045","volume":"26","author":"Y Ota","year":"2018","unstructured":"Ota, Y. et al. Design, synthesis and evaluation of \u03b3-turn mimetics as LSD1-selective inhibitors. Bioorg. Med. Chem. 26, 775\u2013785. https:\/\/doi.org\/10.1016\/j.bmc.2017.12.045 (2018).","journal-title":"Bioorg. Med. Chem."},{"key":"42263_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s10637-023-01330-1","volume":"41","author":"G Yan","year":"2023","unstructured":"Yan, G. et al. Viscosalactone B, a natural LSD1 inhibitor, inhibits proliferation in vitro and in vivo against prostate cancer cells. Invest. New. Drugs. 41, 134\u2013141. https:\/\/doi.org\/10.1007\/s10637-023-01330-1 (2023).","journal-title":"Invest. New. Drugs"},{"key":"42263_CR23","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/j.bmcl.2017.03.081","volume":"27","author":"MT Borrello","year":"2017","unstructured":"Borrello, M. T. et al. Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A). Bioorg. Med. Chem. Lett. 27, 2099\u20132101. https:\/\/doi.org\/10.1016\/j.bmcl.2017.03.081 (2017).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"42263_CR24","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1021\/acs.jmedchem.6b01018","volume":"60","author":"L Sartori","year":"2017","unstructured":"Sartori, L. et al. Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A\/LSD1. Part 1: High-Throughput Screening and Preliminary Exploration. J. Med. Chem. 60, 1673\u20131692. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01018 (2017).","journal-title":"J. Med. Chem."},{"key":"42263_CR25","doi-asserted-by":"publisher","first-page":"107336","DOI":"10.1016\/j.bioorg.2024.107336","volume":"147","author":"K Ahmad Sheikh","year":"2024","unstructured":"Ahmad Sheikh, K. et al. Exploring cyclopropylamine containing cyanopyrimidines as LSD1 inhibitors: Design, synthesis, ADMET, MD analysis and anticancer activity profiling. Bioorg. Chem. 147, 107336. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107336 (2024).","journal-title":"Bioorg. Chem."},{"key":"42263_CR26","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1007\/s00044-023-03046-6","volume":"32","author":"D Al bustanji","year":"2023","unstructured":"Al bustanji, D., Alnabulsi, S. & Al-Hurani, E. A. Hit-to-lead optimization of amino-carboxamide benzothiazoles as LSD1 inhibitors. Med. Chem. Res. 32, 910\u2013929. https:\/\/doi.org\/10.1007\/s00044-023-03046-6 (2023).","journal-title":"Med. Chem. Res."},{"key":"42263_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/life12020264","volume":"12","author":"BC Louren\u00e7o","year":"2022","unstructured":"Louren\u00e7o, B. C. et al. Ki67 and LSD1 expression in testicular germ cell tumors is not associated with patient outcome: Investigation using a digital pathology algorithm. Life 12, 264. https:\/\/doi.org\/10.3390\/life12020264 (2022).","journal-title":"Life"},{"key":"42263_CR28","doi-asserted-by":"publisher","first-page":"106228","DOI":"10.1016\/j.fitote.2024.106228","volume":"179","author":"S Liu","year":"2024","unstructured":"Liu, S. et al. The synthesis and bioactivity of apigenin derivatives. Fitoterapia 179, 106228. https:\/\/doi.org\/10.1016\/j.fitote.2024.106228 (2024).","journal-title":"Fitoterapia"},{"key":"42263_CR29","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3390\/ijms20061305","volume":"20","author":"B Salehi","year":"2019","unstructured":"Salehi, B. et al. The Therapeutic Potential of Apigenin. Int. J. Mol. Sci. 20, 1305. https:\/\/doi.org\/10.3390\/ijms20061305 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"42263_CR30","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1080\/10942912.2016.1207188","volume":"20","author":"F Ali","year":"2017","unstructured":"Ali, F., Rahul, Naz, F., Jyoti, S. & Siddique, Y. H. Health functionality of apigenin: A review. Int. J. Food Prop. 20, 1197\u20131238. https:\/\/doi.org\/10.1080\/10942912.2016.1207188 (2017).","journal-title":"Int. J. Food Prop."},{"key":"42263_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/02652048.2024.2437375","volume":"42","author":"T Vanshita, Rawal","year":"2025","unstructured":"Vanshita, Rawal, T., Bhati, H. & Bansal, K. Harnessing the power of novel drug delivery systems for effective delivery of apigenin: an updated review. J. Microencapsul. 42, 83\u2013106. https:\/\/doi.org\/10.1080\/02652048.2024.2437375 (2025).","journal-title":"J. Microencapsul."},{"key":"42263_CR32","doi-asserted-by":"publisher","first-page":"132178","DOI":"10.1016\/j.foodchem.2022.132178","volume":"379","author":"Y Zhao","year":"2022","unstructured":"Zhao, Y. et al. Lipophilized apigenin derivatives produced during the frying process as novel antioxidants. Food Chem. 379, 132178. https:\/\/doi.org\/10.1016\/j.foodchem.2022.132178 (2022).","journal-title":"Food Chem."},{"key":"42263_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.biopha.2018.06.138","volume":"106","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. Apigenin suppresses mouse peritoneal fibrosis by down-regulating miR34a expression. Biomed. Pharmacother 106, 373\u2013380. https:\/\/doi.org\/10.1016\/j.biopha.2018.06.138 (2018).","journal-title":"Biomed. Pharmacother"},{"key":"42263_CR34","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s00044-022-02933-8","volume":"31","author":"J Jiang","year":"2022","unstructured":"Jiang, J. et al. Research progress on antidiabetic activity of apigenin derivatives. Med. Chem. Res. 31, 1831\u20131841. https:\/\/doi.org\/10.1007\/s00044-022-02933-8 (2022).","journal-title":"Med. Chem. Res."},{"key":"42263_CR35","doi-asserted-by":"publisher","first-page":"36895","DOI":"10.1039\/C8RA07879C","volume":"8","author":"N Umezawa","year":"2018","unstructured":"Umezawa, N. et al. Inhibition of FAD-dependent lysine-specific demethylases by chiral polyamine analogues. RSC Adv. 8, 36895\u201336902. https:\/\/doi.org\/10.1039\/C8RA07879C (2018).","journal-title":"RSC Adv."},{"key":"42263_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejmech.2017.09.073","volume":"141","author":"Y-Y Ji","year":"2017","unstructured":"Ji, Y.-Y. et al. Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitors. Eur. J. Med. Chem. 141, 101\u2013112. https:\/\/doi.org\/10.1016\/j.ejmech.2017.09.073 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"42263_CR37","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1007\/s00018-020-03489-9","volume":"77","author":"F Gu","year":"2020","unstructured":"Gu, F. et al. Biological roles of LSD1 beyond its demethylase activity. Cell. Mol. Life Sci. 77, 3341\u20133350. https:\/\/doi.org\/10.1007\/s00018-020-03489-9 (2020).","journal-title":"Cell. Mol. Life Sci."},{"key":"42263_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201907","volume":"13","author":"ML Duquette","year":"2018","unstructured":"Duquette, M. L., Kim, J., Shi, L. Z. & Berns, M. W. LSD1 mediated changes in the local redox environment during the DNA damage response. PLoS One 13, e0201907. https:\/\/doi.org\/10.1371\/journal.pone.0201907 (2018).","journal-title":"PLoS One"},{"key":"42263_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103404","volume":"77","author":"C Glorieux","year":"2024","unstructured":"Glorieux, C. & Buc Calderon, P. Targeting catalase in cancer. Redox Biol. 77, 103404. https:\/\/doi.org\/10.1016\/j.redox.2024.103404 (2024).","journal-title":"Redox Biol."},{"key":"42263_CR40","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.freeradbiomed.2021.06.010","volume":"172","author":"M Galasso","year":"2021","unstructured":"Galasso, M., Gambino, S., Romanelli, M. G., Donadelli, M. & Scupoli, M. T. Browsing the oldest antioxidant enzyme: Catalase and its multiple regulation in cancer. Free Radic. Biol. Med. 172, 264\u2013272. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.06.010 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"42263_CR41","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1515\/bc.2010.068","volume":"391","author":"S Heinzelmann","year":"2010","unstructured":"Heinzelmann, S. & Bauer, G. Multiple protective functions of catalase against intercellular apoptosis-inducing ROS signaling of human tumor cells. Biol. Chem. 391, 675\u2013693. https:\/\/doi.org\/10.1515\/bc.2010.068 (2010).","journal-title":"Biol. Chem."},{"key":"42263_CR42","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1001\/jama.2025.5884","volume":"334","author":"R Voelker","year":"2025","unstructured":"Voelker, R. What are testicular germ cell tumors?. JAMA 334, 190. https:\/\/doi.org\/10.1001\/jama.2025.5884 (2025).","journal-title":"JAMA"},{"key":"42263_CR43","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41556-022-00848-5","volume":"24","author":"H Li","year":"2022","unstructured":"Li, H. et al. YAP\/TAZ drives cell proliferation and tumour growth via a polyamine\u2013eIF5A hypusination\u2013LSD1 axis. Nat. Cell Biol. 24, 373\u2013383. https:\/\/doi.org\/10.1038\/s41556-022-00848-5 (2022).","journal-title":"Nat. Cell Biol."},{"key":"42263_CR44","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.jtho.2019.06.021","volume":"14","author":"TM Bauer","year":"2019","unstructured":"Bauer, T. M. et al. Phase I, open-label, dose-escalation study of the safety, pharmacokinetics, pharmacodynamics, and efficacy of GSK2879552 in relapsed\/refractory SCLC. J. Thorac. Oncol. 14, 1828\u20131838. https:\/\/doi.org\/10.1016\/j.jtho.2019.06.021 (2019).","journal-title":"J. Thorac. Oncol."},{"key":"42263_CR45","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.1158\/0008-5472.CAN-11-0896","volume":"71","author":"J Wang","year":"2011","unstructured":"Wang, J. et al. Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties. Cancer Res. 71, 7238\u20137249. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-0896 (2011).","journal-title":"Cancer Res."},{"key":"42263_CR46","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2023.12226","volume":"26","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Salsolinol improves angiotensin II\u2011induced myocardial fibrosis in vitro via inhibition of LSD1 through regulation of the STAT3\/Notch\u20111 signaling pathway. Exp. Ther. Med. 26, 527. https:\/\/doi.org\/10.3892\/etm.2023.12226 (2023).","journal-title":"Exp. Ther. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42263-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42263-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42263-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:59:30Z","timestamp":1773395970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-42263-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["42263"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-42263-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8917"}}